Document Classification

Section Type: METHODS

Text: Fifteen patients with atopic persistent asthma were evaluated (mean age, 32. 4 years ; FEV (1), 75. 2 % predicted) in a randomized, double-blind, double-dummy, placebo-controlled crossover study with a 1-week placebo washout period, comparing the following once-daily nighttime treatments : (1) formoterol (FM), 12 microg, for 2 weeks and FM, 24 microg, for 2 weeks ; or (2) budesonide (BUD), 400 microg, for 2 weeks and BUD, 800 microg, for 2 weeks ; or (3) FM, 12 microg, plus BUD, 400 microg, for 2 weeks and FM, 24 microg, plus BUD, 800 microg, for 2 weeks.